<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Biotherapy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Biotherapy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский биотерапевтический журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1726-9784</issn><issn publication-format="electronic">1726-9792</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">804</article-id><article-id pub-id-type="doi">10.17650/1726-9784-2016-15-2-19-23</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Changes in the morphological, immunological and genetic characteristics of Mel Ibr melanoma cells in response to low concentration of embryo calf serum</article-title><trans-title-group xml:lang="ru"><trans-title>Изменение морфологических, иммунологических и генетических характеристик клеток меланомной линии (Mel Ibr) при культивировании в ростовой среде с низкой концентрацией эмбриональной телячьей сыворотки</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Morozova</surname><given-names>L. F.</given-names></name><name xml:lang="ru"><surname>Морозова</surname><given-names>Л. Ф.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Suraeva</surname><given-names>N. M.</given-names></name><name xml:lang="ru"><surname>Сураева</surname><given-names>Наталья Михайловна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nsuraeva@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Burova</surname><given-names>O. S.</given-names></name><name xml:lang="ru"><surname>Бурова</surname><given-names>О. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Voronina</surname><given-names>E. S.</given-names></name><name xml:lang="ru"><surname>Воронина</surname><given-names>Е. С.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Baryshnikova</surname><given-names>M. A.</given-names></name><name xml:lang="ru"><surname>Барышникова</surname><given-names>М. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">N.N. Blokhin Russian Cancer Research Center</institution></aff><aff><institution xml:lang="ru">ФГБУ«Российский онкологический научный центр им. Н.Н. Блохина» Минздрава России</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Research Center for Medical Genetics</institution></aff><aff><institution xml:lang="ru">ФГБНУ«Медико-генетический научный центр»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2016-06-30" publication-format="electronic"><day>30</day><month>06</month><year>2016</year></pub-date><volume>15</volume><issue>2</issue><fpage>19</fpage><lpage>23</lpage><history><date date-type="received" iso-8601-date="2018-04-10"><day>10</day><month>04</month><year>2018</year></date></history><permissions/><self-uri xlink:href="https://bioterapevt.abvpress.ru/jour/article/view/804">https://bioterapevt.abvpress.ru/jour/article/view/804</self-uri><abstract xml:lang="en"><p>Objective: the purpose of the study is research of the changes in phenotypic and genetic characteristics of melanoma cells Mel Ibr cultured in growth medium with low concentration (5 %) of embryo calf serum. Materials and methods. Cell line Меl Ibr was pre-cultured in RPMI-1640 medium with 5 % FBS for 3passages, and then 200-400 cells were replaced on the Petri dish with a diameter of 60 mm and left in the incubator for 14 days to form colonies. Colonies of spindle form cells were cultivated in the same conditions for more than 30 passages. Cells were stained according to the method of Leishman to investigate the morphology. The expression of antigens was determined in the reaction of indirect immunofluorescence. Results. Exposure of Mel Ibr human melanoma cells to low concentration of embryo calf serum resulted in the appearance of a subclone with morphological, immunological and cytogenetical characteristics differed to those of parental cells. The subclone cells distinguished with spindle form, more small size, large nucleus which broadcasted on whole cytoplasm, formation spheroid and sharply reduced percentage of HLA-DR (+) and CD54 (+) cells, a significantly elevated percentage of CD63 (+) cells, and appearance of CD133 (+). The subclone karyotype differed to those of parental cells. Conclusoin. The subclone cells were characterized by the same features as stem tumor cells and could be use as tumor progression model.</p></abstract><trans-abstract xml:lang="ru"><p/></trans-abstract><kwd-group xml:lang="ru"><kwd>сыворотка</kwd><kwd>клеточная линия меланомы</kwd><kwd>опухолевая стволовая клетка</kwd><kwd>субклон</kwd><kwd>serum</kwd><kwd>melanoma cell line</kwd><kwd>tumor stem cell</kwd><kwd>subclone</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Геращенко Т.С., Денисов Е.В., Литвяков Н.В. и др. Внутриопухолевая гетерогенность: природа и биологическое значение. Биохимия 2013;78(11):1531-49.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Сураева Н.М., Морозова Л.Ф., Самойлов А.В. и др. Изменение морфологических и иммунологических характеристик клеток меланомной линии (MEL IBR) в результате воздействия куриного эмбрионального экстракта. Бюллетень экспериментальной биологии и медицины 2015;159(4):521-4.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Сураева Н.М., Самойлов А.В. Получение фармацевтических белков с помощью трансгенной птицы. Вестник РОНЦ им. Н.Н. Блохина РАМН 2009;20(4):19-25.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Барышников А.Ю. Моноклональные антитела серии ИКО к дифференциро-вочным антигенам лимфоцитов человека. Гематология и трансфузиология 1990;8:4-7.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Short protocols in human genetics: a compendium of methods from current protocols in human genetics. N.C. Dracopoli et al. (eds.). New York: Willey, 2004.</mixed-citation></ref></ref-list></back></article>
